Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiska uppgifter
Huvudupphovsman:	Paul, Pulock
Övriga upphovsmän:	Azam,Faruque
Materialtyp:	Lärdomsprov
Språk:	English
Publicerad:	Brac University 2024
Ämnen:	Lung cancer Clinical trial Efficacy endpoints Targeted therapy Lungs > Cancer Clinical trials Chemotherapy
Länkar:	http://hdl.handle.net/10361/23954

Liknande verk

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
av: Rahman, Tasnim
Publicerad: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
av: Hoque, Ismoth Ara
Publicerad: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Flora, Sanzida Alam
Publicerad: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Karim, Samia Binte
Publicerad: (2024)

A review on targeted therapies for lung cancer
av: Ashraf, Anushey
Publicerad: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
av: Tania, Umme
Publicerad: (2023)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
av: Shobnam, Sohana
Publicerad: (2024)

Molecules associated with the development of lung cancer
av: Rahman, Adree, et al.
Publicerad: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
av: Razna, Amrin Islam
Publicerad: (2019)

Protein biomarkers for Lung Cancer: a bioinformatic approach
av: Jeba, Joynob
Publicerad: (2017)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
av: Hasan, Sakib
Publicerad: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
av: Bristy, Israt Zerin
Publicerad: (2021)

Potential of liposomes for the treatment of lung cancer- a review
av: Mim, Shanzida
Publicerad: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
av: Zangmo, Thinley
Publicerad: (2024)

A review on recent advances in drugs for lung cancer treatment
av: Noor, Fouzia
Publicerad: (2024)

Immunotherapy in the Management of Lung Cancer
av: Tasnim, Humayra
Publicerad: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
av: Pial, Sazia Afrin
Publicerad: (2018)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
av: Shabnam, Musharrat
Publicerad: (2018)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
av: Akter, Rabia
Publicerad: (2024)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
av: Das, Reshita
Publicerad: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
av: Oishy, Jannatun Noor
Publicerad: (2024)

Lung cancer detection and classification using machine learning
av: Arefin, Mahbubul, et al.
Publicerad: (2023)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
av: Monayem, Kazi Fahim
Publicerad: (2024)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
av: Mukti, Roushney Fatima, et al.
Publicerad: (2016)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
av: Nandy, Aditi
Publicerad: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
av: Rahman, Sanjida
Publicerad: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
av: Abir, Shifaty Nur
Publicerad: (2024)

Gene therapy for rare genetic disorders
av: Tanjum, Atia
Publicerad: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
av: Alam, Kazi Tasnuva
Publicerad: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
av: Meem, Manila
Publicerad: (2023)

Trend in approval of targeted biologics in the last two decades
av: Siddika, Khadiza
Publicerad: (2024)

The hidden histories of war crimes trials /

A review on drug repurposing for diabetes epidemic
av: Lamia, Sadia Raisa
Publicerad: (2022)

Changing global policy to deliver safe, equitable, and affordable care for women's cancers
av: Ginsburg, Ophira M., et al.
Publicerad: (2018)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
av: Hasan, Amit
Publicerad: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
av: Raihan, Dilraj
Publicerad: (2024)

Update on pharmacological aspects of carotenoids: molecules of pharmaceutical promise
av: Labanna, Marium Akther
Publicerad: (2022)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
av: F. S. Amaral, André, et al.
Publicerad: (2017)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
av: Nahar, Kamrun
Publicerad: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
av: Jahan, Nusrat
Publicerad: (2024)